A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
Scientists at the New York Stem Cell Foundation and CUMC have created the first disease-specific embryonic stem cell line using nuclear transfer technology.
Obese children exposed to high levels of air pollutants are nearly three times as likely to have asthma, compared with non-obese children and lower levels of pollution exposure.
Women with PTSD gain weight more rapidly and are more likely to be overweight or obese than women without the disorder, find researchers at Columbia University’s Mailman School of Public Health and Harvard School of Public Health.